Those who work in the medical field are very aware of the consequences that can come from a HIPAA violation, which is certainly in the context of the Health Insurance Portability and Accountability Act, a federal law that protects sensitive patient information. Protects. HIPAA, which was established in 1996, protects a patient’s health information until a patient provides consent. Most health workers respect HIPAA legislation, ensuring that they do not violate themselves.
With that being said, does future digital evidence count as a violation of HIPAA laws? Many of us who have been vaccinated for novel coronaviruses already have a paper verification card, which proves that we have been treated with a vaccine, but there may be a possibility of a vaccine passport, such as The latest Excelsior pass in New York could possibly be in violation. HIPAA Law? Let in
New York recently launched the first US state-administered digital health app, called Excelsior Pass. This vaccine passport program runs on an IBM blockchain that crosses patient data with state health records. It should be noted that IBM cannot access personally identifiable data, which must scan only a QR code for vaccination validation.
Landing across the country and on the West Coast is Carbon Health, which is assisting in the vaccination process in the cities of Los Angeles and San Mateo. This California startup has actually become one of the first organizations to launch a HIPAA-compliant digital vaccine card.
Carbon Health CEO Aren Bali said the following Emerging Tech Brew: “As vaccination ramps up, we speculate that more organizations will request proof of vaccination, travel, or go to music and ceremonies to allow people inside buildings or businesses. “ Given that we are living in a partially vaccinated place, having digital vaccination evidence at entry or reentry can be a hindrance, as if the passport process is not difficult.
Governments are currently considering the need for a vaccine passport to travel, a move that many proponents claim will allow holders to travel safely as well as without worrying about infecting others on their own Will gain a sense of normalization of life. This, on top of many good things, will also be an added incentive for those who are unsure about getting the vaccine.
However, doubts about vaccine passports and fears of HIPAA violations are raising some ethical questions, including the fact that it may discriminate against minority communities, as well as allow businesses to access private information. Can.
Equally, mutations of COVID-19 can complicate the overall vaccine passport, as it can create many essential passports. Finally, there are concerns about the fact that most children cannot be vaccinated until 2022, given how the U.S. There is only in clinical trials for a safe vaccine that effectively works for children and some young adults.
According to recent data released by the Centers for Disease Control and Prevention, 15.8% of US citizens have been fully vaccinated for coronavirus.
To date, there are three vaccines that are being used to fight the spread of COVID-19 and to end the current global epidemic in the US. The first vaccine was produced by Pfizer-BioNTech, first administered in the US in late 2020. A second vaccine to fight the coronavirus was developed by Modern, which was first given a green light for emergency use at the 2020 tail-end.
Both of these coronavirus vaccines are estimated to be combating coronoviruses with an efficacy rate greater than 90%. However, both vaccines currently require two different doses, each of which requires several weeks to produce appropriate antibodies for protection from malignant disease.
This time the third coronavirus vaccine, developed by Johnson & Johnson, was given CDC approval in February. This vaccine has an effectiveness rate of over 85% and requires only one shot. While there is a fourth vaccine by AstraZeneca, which is said to have an effectiveness rate of 70%, it is not a vaccine being used in the US, but in the UK, currently on pause due to growing concerns of side effects such as blood clots. . .